Cargando…

Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis

BACKGROUND: The purpose of this study was to assess the effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes. METHODS: We searched PubMed, EMBASE, Cochrane Central, and the Web of Science to December 2021. The el...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Su Lim, Hwang, Yoo Na, Kwon, Ji Yean, Kim, Sung Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733359/
https://www.ncbi.nlm.nih.gov/pubmed/36494830
http://dx.doi.org/10.1186/s13098-022-00962-2
_version_ 1784846356618149888
author Kang, Su Lim
Hwang, Yoo Na
Kwon, Ji Yean
Kim, Sung Min
author_facet Kang, Su Lim
Hwang, Yoo Na
Kwon, Ji Yean
Kim, Sung Min
author_sort Kang, Su Lim
collection PubMed
description BACKGROUND: The purpose of this study was to assess the effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes. METHODS: We searched PubMed, EMBASE, Cochrane Central, and the Web of Science to December 2021. The eligibility criteria for study selection were randomized controlled trials comparing artificial pancreas systems (MPC, PID, and fuzzy algorithms) with conventional insulin therapy in type 1 diabetes patients. The heterogeneity of the overall results was identified by subgroup analysis of two factors including the intervention duration (overnight and 24 h) and the follow-up periods (< 1 week, 1 week to 1 month, and > 1 month). RESULTS: The meta-analysis included a total of 41 studies. Considering the effect on the percentage of time maintained in the target range between the MPC-based artificial pancreas and conventional insulin therapy, the results showed a statistically significantly higher percentage of time maintained in the target range in overnight use (10.03%, 95% CI [7.50, 12.56] p < 0.00001). When the follow-up period was considered, in overnight use, the MPC-based algorithm showed a statistically significantly lower percentage of time maintained in the hypoglycemic range (−1.34%, 95% CI [−1.87, −0.81] p < 0.00001) over a long period of use (> 1 month). CONCLUSIONS: Overnight use of the MPC-based artificial pancreas system statistically significantly improved glucose control while increasing time maintained in the target range for outpatients with type 1 diabetes. Results of subgroup analysis revealed that MPC algorithm-based artificial pancreas system was safe while reducing the time maintained in the hypoglycemic range after an overnight intervention with a long follow-up period (more than 1 month). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-022-00962-2.
format Online
Article
Text
id pubmed-9733359
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97333592022-12-10 Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis Kang, Su Lim Hwang, Yoo Na Kwon, Ji Yean Kim, Sung Min Diabetol Metab Syndr Review BACKGROUND: The purpose of this study was to assess the effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes. METHODS: We searched PubMed, EMBASE, Cochrane Central, and the Web of Science to December 2021. The eligibility criteria for study selection were randomized controlled trials comparing artificial pancreas systems (MPC, PID, and fuzzy algorithms) with conventional insulin therapy in type 1 diabetes patients. The heterogeneity of the overall results was identified by subgroup analysis of two factors including the intervention duration (overnight and 24 h) and the follow-up periods (< 1 week, 1 week to 1 month, and > 1 month). RESULTS: The meta-analysis included a total of 41 studies. Considering the effect on the percentage of time maintained in the target range between the MPC-based artificial pancreas and conventional insulin therapy, the results showed a statistically significantly higher percentage of time maintained in the target range in overnight use (10.03%, 95% CI [7.50, 12.56] p < 0.00001). When the follow-up period was considered, in overnight use, the MPC-based algorithm showed a statistically significantly lower percentage of time maintained in the hypoglycemic range (−1.34%, 95% CI [−1.87, −0.81] p < 0.00001) over a long period of use (> 1 month). CONCLUSIONS: Overnight use of the MPC-based artificial pancreas system statistically significantly improved glucose control while increasing time maintained in the target range for outpatients with type 1 diabetes. Results of subgroup analysis revealed that MPC algorithm-based artificial pancreas system was safe while reducing the time maintained in the hypoglycemic range after an overnight intervention with a long follow-up period (more than 1 month). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-022-00962-2. BioMed Central 2022-12-09 /pmc/articles/PMC9733359/ /pubmed/36494830 http://dx.doi.org/10.1186/s13098-022-00962-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Kang, Su Lim
Hwang, Yoo Na
Kwon, Ji Yean
Kim, Sung Min
Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis
title Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis
title_full Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis
title_fullStr Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis
title_full_unstemmed Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis
title_short Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis
title_sort effectiveness and safety of a model predictive control (mpc) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (t1d): systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733359/
https://www.ncbi.nlm.nih.gov/pubmed/36494830
http://dx.doi.org/10.1186/s13098-022-00962-2
work_keys_str_mv AT kangsulim effectivenessandsafetyofamodelpredictivecontrolmpcalgorithmforanartificialpancreassysteminoutpatientswithtype1diabetest1dsystematicreviewandmetaanalysis
AT hwangyoona effectivenessandsafetyofamodelpredictivecontrolmpcalgorithmforanartificialpancreassysteminoutpatientswithtype1diabetest1dsystematicreviewandmetaanalysis
AT kwonjiyean effectivenessandsafetyofamodelpredictivecontrolmpcalgorithmforanartificialpancreassysteminoutpatientswithtype1diabetest1dsystematicreviewandmetaanalysis
AT kimsungmin effectivenessandsafetyofamodelpredictivecontrolmpcalgorithmforanartificialpancreassysteminoutpatientswithtype1diabetest1dsystematicreviewandmetaanalysis